Production (Stage)
IN8bio, Inc.
INAB
$3.08
-$1.09-26.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 11.58M | 12.64M | 13.08M | 13.73M | 13.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | 330.00K | 330.00K | 330.00K |
| Total Operating Expenses | 26.61M | 29.60M | 31.30M | 32.43M | 31.46M |
| Operating Income | -26.61M | -29.60M | -31.30M | -32.43M | -31.46M |
| Income Before Tax | -27.43M | -30.44M | -31.88M | -31.96M | -31.04M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.43 | -30.44 | -31.88 | -31.96 | -31.04 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.43M | -30.44M | -31.88M | -31.96M | -31.04M |
| EBIT | -26.61M | -29.60M | -31.30M | -32.43M | -31.46M |
| EBITDA | -24.73M | -27.76M | -29.50M | -30.63M | -29.61M |
| EPS Basic | -14.62 | -18.56 | -22.74 | -25.07 | -27.46 |
| Normalized Basic EPS | -8.71 | -11.18 | -13.79 | -15.67 | -17.16 |
| EPS Diluted | -14.73 | -18.63 | -22.81 | -25.14 | -27.53 |
| Normalized Diluted EPS | -8.71 | -11.18 | -13.79 | -15.67 | -17.16 |
| Average Basic Shares Outstanding | 8.43M | 7.10M | 5.68M | 5.15M | 4.60M |
| Average Diluted Shares Outstanding | 8.43M | 7.10M | 5.68M | 5.15M | 4.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |